Insights

Strategic Partnerships Deciphera Pharmaceuticals has established strategic partnerships with companies like Zai Lab Limited for the development and commercialization of key products in specific regions, presenting collaboration opportunities for mutual growth and market expansion.

Recent Investments Recent investments by Sunesis Advisors LLC indicate confidence in Deciphera Pharmaceuticals' potential, suggesting potential opportunities for partnership or investment from other entities looking to capitalize on the company's growth prospects.

Personnel Recruitment The hiring of key personnel like Kelley Dealhoy as Vice President of Business Development signifies a focus on expanding business operations, presenting networking opportunities for sales professionals to leverage existing and upcoming business prospects.

Product Launches Deciphera Pharmaceuticals' successful launch of products like Qinlock in specific regions such as Germany and France demonstrates market readiness, offering sales professionals opportunities to promote and distribute the company's innovative medicines in those markets.

Industry Recognition Being positioned at the top of the Drug Manufacturers - Specialty & Generic industry reflects Deciphera Pharmaceuticals' industry leadership and reputation, opening doors for sales development representatives to engage with potential clients seeking high-quality pharmaceutical solutions.

Deciphera Pharmaceuticals Tech Stack

Deciphera Pharmaceuticals uses 8 technology products and services including Google Analytics, QlikView, Fastly, and more. Explore Deciphera Pharmaceuticals's tech stack below.

  • Google Analytics
    Analytics
  • QlikView
    Business Intelligence
  • Fastly
    Content Delivery Network
  • MySQL
    Database
  • Crowdstrike
    Endpoint Protection
  • Cisco
    Network Hardware
  • Microsoft Azure
    Platform As A Service
  • Nginx
    Web Servers

Media & News

Deciphera Pharmaceuticals's Email Address Formats

Deciphera Pharmaceuticals uses at least 1 format(s):
Deciphera Pharmaceuticals Email FormatsExamplePercentage
flast@deciphera.comJDoe@deciphera.com
76%
first.last@deciphera.comJohn.Doe@deciphera.com
14%
firstlast@deciphera.comJohnDoe@deciphera.com
8%
last@deciphera.comDoe@deciphera.com
2%

Frequently Asked Questions

Where is Deciphera Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Deciphera Pharmaceuticals's main headquarters is located at 200 Smith St Waltham, Massachusetts 02451 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Deciphera Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Deciphera Pharmaceuticals's main corporate office by phone at +1-781-209-6400. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Deciphera Pharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
Deciphera Pharmaceuticals is a publicly traded company; the company's stock symbol is DCPH.

What is Deciphera Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Deciphera Pharmaceuticals's official website is deciphera.com and has social profiles on LinkedIn.

How much revenue does Deciphera Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of June 2024, Deciphera Pharmaceuticals's annual revenue reached $75M.

What is Deciphera Pharmaceuticals's NAICS code?

Minus sign iconPlus sign icon
Deciphera Pharmaceuticals's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Deciphera Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of June 2024, Deciphera Pharmaceuticals has approximately 404 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Development Officer Cdo: J. J. P.Chief Scientific Officer: D. D.Chief Commercial Officer & Head Of New Product Strategy: D. M.. Explore Deciphera Pharmaceuticals's employee directory with LeadIQ.

What industry does Deciphera Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Deciphera Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Deciphera Pharmaceuticals use?

Minus sign iconPlus sign icon
Deciphera Pharmaceuticals's tech stack includes Google AnalyticsQlikViewFastlyMySQLCrowdstrikeCiscoMicrosoft AzureNginx.

What is Deciphera Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Deciphera Pharmaceuticals's email format typically follows the pattern of . Find more Deciphera Pharmaceuticals email formats with LeadIQ.

How much funding has Deciphera Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of June 2024, Deciphera Pharmaceuticals has raised $125M in funding. The last funding round occurred on Jan 19, 2023.

When was Deciphera Pharmaceuticals founded?

Minus sign iconPlus sign icon
Deciphera Pharmaceuticals was founded in 2003.
Deciphera Pharmaceuticals

Deciphera Pharmaceuticals

Pharmaceutical ManufacturingMassachusetts, United States201-500 Employees

Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. For more information, visit www.deciphera.com.

Section iconCompany Overview

Headquarters
200 Smith St Waltham, Massachusetts 02451 US
Phone number
+1-781-209-6400
Stock Symbol
DCPH
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2003
Employees
201-500

Section iconFunding & Financials

  • $125M

    Deciphera Pharmaceuticals has raised a total of $125M of funding over 7 rounds. Their latest funding round was raised on Jan 19, 2023.

  • $50M$100M

    Deciphera Pharmaceuticals's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $125M

    Deciphera Pharmaceuticals has raised a total of $125M of funding over 7 rounds. Their latest funding round was raised on Jan 19, 2023.

  • $50M$100M

    Deciphera Pharmaceuticals's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.